Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients With Fingolimod Treatment (Vol 60, Pg 23, 2023)

Terzi, MuratHelvaci, Elif MerveSen, SedatBoz, CavitCilingir, VedatAkcali, AylinTerzi, Yuksel2025-05-102025-05-1020231300-06671309-486610.29399/npa.284992-s2.0-85164255146https://doi.org/10.29399/npa.28499https://hdl.handle.net/20.500.14720/10365Yoldas, Tahir Kurtulus/0000-0003-4950-9142; Ozturk, Bilgin/0000-0002-8899-9925; Turkoglu, Recai/0000-0001-9724-851X; Kotan, Dilcan/0000-0002-3101-4742; Sen, Sedat/0000-0001-8048-6845; Aydin Turkoglu, Sule/0000-0001-8616-832Xeninfo:eu-repo/semantics/closedAccessClinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients With Fingolimod Treatment (Vol 60, Pg 23, 2023)Correction602Q4Q419019037287556WOS:001021642100017